LSE:GSKPharmaceuticals
Is It Too Late To Consider GSK (LSE:GSK) After Its Strong 1-Year Share Price Run?
If you are wondering whether GSK at £18.86 is still a sensible entry point or is starting to look expensive, you are exactly who this valuation focused breakdown is for.
The stock has returned 3.0% over the last 7 days, 4.6% over the last 30 days, 3.0% year to date and 45.9% over the last year, with 48.4% over 3 years and 65.0% over 5 years, which naturally raises questions about how much value is currently priced in.
Recent market attention has focused on GSK's positioning as a major...